U.S. Market for Tamper Evident Caps for IV & Oral Syringes


Naperville, IL -- (SBWIRE) -- 01/21/2015 -- Reportstack, provider of premium market research reports announces the addition of U.S. Market for Tamper Evident Caps for IV & Oral Syringes market report to its offering

In 2012, it expected there were be over 40 million tamper evident caps sold in the U.S., an increase of over the previous year. This market is being driven by the growth in the plastic and glass prefilled syringes segment and by the increased penetration of tamper evident devices for these prefilled syringes.

For plastic prefilled syringes, the majority of them are filled with either saline or heparin, and because these solution are not caustic or controlled substances, it is unlikely that they will use any type of tamper evident device because it is not cost effective. However, the remaining 1% of the plastic prefilled syringes that contain vaccines, cough medicine and pain relief medication may use a tamper evident device, and tamper evident caps have the potential to increase their penetration rate in that subsegment. Glass prefilled syringes are almost exclusively filled with drugs instead of heparin or flushing solutions, and while the penetration rate for tamper evident caps for glass prefilled syringes is relatively low, there is great potential for all types of tamper evident devices to increase their use with glass prefilled syringes.

Scope: This report pertains to a forecast period of 10 years (2008 – 2018) for the U.S.

Report Contents:

Competitor Analysis

Identified Strategic Opportunities

Market Overview by Segment

Trend Analysis by Segment

Market Drivers & Limiters

Mergers & Acquisitions

Customer Feedback and Market Monitoring

Main Segments Included:

Prefilled Syringes and Tamper Evident Devices

Prefilled Syringe Administration Types

Sub-Segments Included:

Oral Tamper Evident Cap Market

Sterile Tamper Evident Cap Market

Plastic Prefilled Syringes

Glass Prefilled Syringes

Companies Included:

PharMEDium/B. Braun

International Medical Industries


Health Care Logistics

Baxa Corporation/Baxter International


Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up� approach, which includes primary and secondary research methods.

Complete report is available

Roger Campbell
United States
Ph: 888-789-6604